The role of adiponectin in conditions such as atherosclerosis and obesity has limited its use as a prognostic indicator for cardiovascular disease (CVD) in the general population [110–112] and as a biomarker for psoriasis patients with CVD [113]. This evidence concerns the gene ADIPOQ and obesity due to melanocortin 4 receptor deficiency.